Abel Hall LLC’s Organogenesis Holdings ORGO Stock Holding History

Abel Hall LLC’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$174K	Buy	+71,653	New	+$175K	0.03%	767

Other funds holding ORGO

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Sentinel Trust Houston, Texas $1.13B AUM 24.31% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

Abel Hall LLC's ORGO Position: Q2 2026 in Review

Abel Hall LLC opened a new position in Organogenesis Holdings (ORGO) in Q2 2026: 71,653 shares worth $174K. The stake represents 0.03% of the portfolio and ranks #767 among its holdings.

25 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

Abel Hall LLC held 71,653 shares of Organogenesis Holdings worth $174K as of Q2 2026.
Organogenesis Holdings was a new Abel Hall LLC position in Q2 2026.
Organogenesis Holdings made up 0.03% of Abel Hall LLC's portfolio in Q2 2026, its #767 holding.
25 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.